Andy Watt

2.5k total citations
12 papers, 1.0k citations indexed

About

Andy Watt is a scholar working on Molecular Biology, Hematology and Cancer Research. According to data from OpenAlex, Andy Watt has authored 12 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Hematology and 3 papers in Cancer Research. Recurrent topics in Andy Watt's work include RNA modifications and cancer (3 papers), Cancer-related molecular mechanisms research (3 papers) and Iron Metabolism and Disorders (3 papers). Andy Watt is often cited by papers focused on RNA modifications and cancer (3 papers), Cancer-related molecular mechanisms research (3 papers) and Iron Metabolism and Disorders (3 papers). Andy Watt collaborates with scholars based in United States and Australia. Andy Watt's co-authors include Brett P. Monia, Sue Freier, Sheri Booten, Shuling Guo, Christopher Benner, David Gosselin, Christopher K. Glass, Han Cho, Hanna P. Lesch and Sven Heinz and has published in prestigious journals such as Nature, Nucleic Acids Research and Journal of Clinical Investigation.

In The Last Decade

Andy Watt

11 papers receiving 995 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andy Watt United States 7 678 203 187 180 115 12 1.0k
Ngoc-Bich Nguyen United States 7 304 0.4× 103 0.5× 161 0.9× 126 0.7× 42 0.4× 8 618
Shiho Kodama Japan 12 253 0.4× 106 0.5× 73 0.4× 76 0.4× 79 0.7× 17 569
Gaspard Cretenet Netherlands 8 301 0.4× 61 0.3× 161 0.9× 35 0.2× 107 0.9× 19 817
Dharmaraj Chinnappan United States 11 1.5k 2.3× 87 0.4× 125 0.7× 43 0.2× 298 2.6× 21 2.0k
Ashley C. Kramer United States 13 490 0.7× 53 0.3× 58 0.3× 131 0.7× 23 0.2× 28 653
Jit Kong Cheong Singapore 13 710 1.0× 32 0.2× 160 0.9× 31 0.2× 73 0.6× 24 925
Jean‐Pierre Gagner United States 12 329 0.5× 207 1.0× 185 1.0× 9 0.1× 56 0.5× 17 798
Duncan B. Johnstone United States 13 450 0.7× 64 0.3× 69 0.4× 22 0.1× 53 0.5× 16 844
Emery H. Bresnick United States 22 1.5k 2.2× 189 0.9× 114 0.6× 276 1.5× 119 1.0× 26 1.7k
Nicholas Shukeir Germany 14 1.2k 1.8× 25 0.1× 185 1.0× 39 0.2× 92 0.8× 17 1.4k

Countries citing papers authored by Andy Watt

Since Specialization
Citations

This map shows the geographic impact of Andy Watt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andy Watt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andy Watt more than expected).

Fields of papers citing papers by Andy Watt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andy Watt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andy Watt. The network helps show where Andy Watt may publish in the future.

Co-authorship network of co-authors of Andy Watt

This figure shows the co-authorship network connecting the top 25 collaborators of Andy Watt. A scholar is included among the top collaborators of Andy Watt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andy Watt. Andy Watt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Damle, Sagar, Andy Watt, Steven Kuntz, et al.. (2025). A Workflow for Transcriptome-Wide Assessment of Antisense Oligonucleotide Selectivity. Nucleic Acid Therapeutics. 35(6). 249–260.
2.
Qiao, Yuanyuan, Jesse W. Wotring, Charles J. Zhang, et al.. (2023). Antisense oligonucleotides to therapeutically target SARS-CoV-2 infection. PLoS ONE. 18(2). e0281281–e0281281. 11 indexed citations
3.
Zhang, Xihong, et al.. (2023). Techno-Economic and Environmental Analysis of Decommissioned Flowline, Umbilical, and Tubular for Breakwaters. Buildings. 13(1). 225–225. 3 indexed citations
4.
5.
Ackermann, Elizabeth J., Shuling Guo, Merrill D. Benson, et al.. (2016). Suppressing transthyretin production in mice, monkeys and humans using 2nd-Generation antisense oligonucleotides. Amyloid. 23(3). 148–157. 114 indexed citations
6.
Burel, Sebastien A., Christopher E. Hart, Todd Machemer, et al.. (2015). Hepatotoxicity of high affinity gapmer antisense oligonucleotides is mediated by RNase H1 dependent promiscuous reduction of very long pre-mRNA transcripts. Nucleic Acids Research. 44(5). 2093–2109. 148 indexed citations
7.
Huang, Lulu, Sagar Damle, Sheri Booten, et al.. (2015). Partial Hepatectomy Induced Long Noncoding RNA Inhibits Hepatocyte Proliferation during Liver Regeneration. PLoS ONE. 10(7). e0132798–e0132798. 26 indexed citations
8.
Murray, Susan, Michael T. Matthes, Douglas Yasumura, et al.. (2015). Allele-Specific Inhibition of Rhodopsin With an Antisense Oligonucleotide Slows Photoreceptor Cell Degeneration. Investigative Ophthalmology & Visual Science. 56(11). 6362–6362. 83 indexed citations
9.
Lam, Michael T., Han Cho, Hanna P. Lesch, et al.. (2013). Rev-Erbs repress macrophage gene expression by inhibiting enhancer-directed transcription. Nature. 498(7455). 511–515. 434 indexed citations
10.
Guo, Shuling, Carla Casu, Sara Gardenghi, et al.. (2013). Reducing TMPRSS6 ameliorates hemochromatosis and β-thalassemia in mice. Journal of Clinical Investigation. 123(4). 1531–1541. 184 indexed citations
11.
Guo, Shuling, Carla Casu, Sara Gardenghi, et al.. (2012). Target TMPRSS6 Using Antisense Technology for the Treatment of Hereditary Hemochromatosis and β-Thalassemia. Blood. 120(21). 481–481. 1 indexed citations
12.
Crosby, Jeffrey R., et al.. (2006). Targeting Hepcidin with Antisense Oligonucletides Improves Anemia Endpoints in Mice.. Blood. 108(11). 269–269. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026